SCHEMBL31455832

SCHEMBL31455832

COC(=O)c1ccc(C(=O)Nc2ccc(Nc3cc(OC(F)(F)F)ccc3N)cn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 2/20 0.46
HDAC1 Q13547 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CXCR2 P25025 2/20 0.44
ALDH1A1 P00352 2/20 0.44
LMNA P02545 1/20 0.44
PTGS1 P23219 2/20 0.43
DEGS1 O15121 1/20 0.43
TRPV1 Q8NER1 1/20 0.43
TP53 P04637 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455603 0.85 MEN1 (0.45) F10MEN1KMT2APOLBMAPT
SCHEMBL31455923 0.82 RAB9A (0.61) MEN1KMT2APOLBMAPTHDAC1
SCHEMBL31455231 0.80 KDR (0.46) MEN1KMT2ANPC1RAB9ATP53
SCHEMBL3492544 0.78 HDAC1 (0.52) MAPTHDAC1NPC1RAB9AALDH1A1
SCHEMBL31456002 0.73 MEN1 (0.49) MEN1KMT2APOLBMAPTRXFP1
SCHEMBL23657478 0.72 KDM4E (0.67) F10POLBMAPTNPC1RAB9A
SCHEMBL2342925 0.71 GAA (0.51) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL17942189 0.71 MAPT (0.64) F10MAPTHDAC1NPC1RAB9A
SCHEMBL31455675 0.70 MAPT (0.54) MEN1KMT2APOLBMAPTRXFP1
SCHEMBL31455726 0.69 MAPT (0.49) MEN1KMT2APOLBMAPTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059562-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS AND METHODS OF TREATING DISEASE USING SAME ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed